BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16212919)

  • 1. T lymphocyte co-signaling pathways of the B7-CD28 family.
    Wang S; Chen L
    Cell Mol Immunol; 2004 Feb; 1(1):37-42. PubMed ID: 16212919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma.
    Chen YQ; Shi HZ
    Allergy; 2006 Jan; 61(1):15-26. PubMed ID: 16364152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.
    Chen L
    Nat Rev Immunol; 2004 May; 4(5):336-47. PubMed ID: 15122199
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
    Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND
    Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
    Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
    Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A more selective costimulatory blockade of the CD28-B7 pathway.
    Poirier N; Blancho G; Vanhove B
    Transpl Int; 2011 Jan; 24(1):2-11. PubMed ID: 20964725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular aspects of regulatory T cell development.
    Fontenot JD; Rudensky AY
    Semin Immunol; 2004 Apr; 16(2):73-80. PubMed ID: 15036230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
    Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
    Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses.
    Wang S; Chen L
    Microbes Infect; 2004 Jul; 6(8):759-66. PubMed ID: 15207823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
    J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties.
    Bhatia S; Edidin M; Almo SC; Nathenson SG
    Immunol Lett; 2006 Apr; 104(1-2):70-5. PubMed ID: 16413062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B7/CD28 costimulatory family in autoimmunity.
    Keir ME; Sharpe AH
    Immunol Rev; 2005 Apr; 204():128-43. PubMed ID: 15790355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune regulation by novel costimulatory molecules.
    Dong C; Nurieva RI; Prasad DV
    Immunol Res; 2003; 28(1):39-48. PubMed ID: 12947223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
    Mukherjee S; Ahmed A; Malu S; Nandi D
    J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.